Previous 10 | Next 10 |
Co-Diagnostics, Inc. (CODX) Q3 2022 Earnings Conference Call November 10, 2022, 04:30 PM ET Company Participants Dan Bohrer - VP, Finance and Accounting Dwight Egan - CEO Brian Brown - CFO Conference Call Participants Theodore O'Neill - Litchfield Hil...
Co-Diagnostics press release ( NASDAQ: CODX ): Q3 GAAP EPS of -$0.04. Revenue of $5.1M (-83.1% Y/Y). For further details see: Co-Diagnostics GAAP EPS of -$0.04, revenue of $5.1M
Co-Diagnostics, Inc. Reports Third Quarter 2022 Financial Results PR Newswire Nearing commencement of clinical evaluations for the Co-Dx PCR Home platform COVID-19 test volumes continue to impact third quarter results SALT LAKE CITY , Nov. 10, 2...
Co-Diagnostics ( NASDAQ: CODX ) is scheduled to announce Q3 earnings results on Thursday, November 10th, after market close. The consensus EPS Estimate is -$0.03 and the consensus Revenue Estimate is $7.48M (-75.1% Y/Y). Over the last 1 year, CODX has beaten EPS esti...
Co-Diagnostics, Inc. to Host Booth at AMP This Week in Phoenix, AZ PR Newswire SALT LAKE CITY , Nov. 3, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patente...
Co-Diagnostics, Inc. Appoints Dr. Mark Poritz as New Chief Scientific Officer PR Newswire SALT LAKE CITY , Nov. 1, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx™" or the "Company"), a molecular diagnostics company with a...
CO-DIAGNOSTICS, INC. ANNOUNCES THIRD QUARTER 2022 EARNINGS RELEASE DATE AND WEBCAST PR Newswire SALT LAKE CITY , Oct. 27, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for t...
Co-Diagnostics, Inc. to Host Booth at Medlab Africa on Oct 26-28 in South Africa PR Newswire SALT LAKE CITY , Oct. 26, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a ...
Co-Diagnostics, Inc. to Host Booths at Conferences in Washington, D.C. and Bangkok, Thailand PR Newswire SALT LAKE CITY , Oct. 19, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics com...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips As people acclimatize to the new normal, it’s time to look at some vaccine stocks to sell. Instead of relying primarily on vaccines and antiviral drugs, the government let people manage infections. Once infected wi...
News, Short Squeeze, Breakout and More Instantly...
Co-Diagnostics, Inc. Announces First Quarter 2024 Earnings Release Date and Webcast PR Newswire SALT LAKE CITY , April 25, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the developme...
Co-Diagnostics, Inc. to Host Booth and Deliver Presentation at APRC 2024 in Taiwan PR Newswire SALT LAKE CITY , April 24, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, pate...
Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event PR Newswire Ribbon-cutting included support from Mayor Wood of South Salt Lake and other dignitaries SALT LAKE CITY , April 12, 2024 /PRNewswire/ -- ...